Top Pharmaceutical Startups in Switzerland (2025 Update)
Explore the best Pharmaceutical companies in Switzerland. Discover high-growth startups and investment opportunities in our 2025 updated list.
👋🏼 Hi, I'm Bounce Watch. Let's explore what's happening in Top Pharmaceutical Startups in Switzerland!
Real-Time Scouting Assistant

Explore Top Pharmaceutical Startups in Switzerland featuring 152 Companies
|
![]() |
|||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MetrioPharm | - | At the Forefront of Macrophage Metabolic Modulation | MetrioPharm AG is a Swiss biotech company developing first-in-class auto-regulat... | - |
|
Zurich | Switzerland (HQ) + 1 | 2007 | Biotechnology, Health Care +1 | - |
1
Low
|
20
|
627 (-100%) | 2 years ago | Grant | 2 | 20.3M | 910 | 8 months ago | ||
|
TOLREMO therapeutics | - | Stopping non-genetic cancer drug resistance as it emerges | TOLREMO therapeutics' mission is to prevent non-genetic cancer drug resistance b... | - |
|
Basel | Switzerland (HQ) | 2017 | Biotechnology, Pharmaceutical | [email protected] |
1
Low
|
14
|
156 (-100%) | 1 year ago | Series A | 4 | 19.5M | 5046 | 5 months ago | ||
|
Pharvaris | - | Pioneering science for patient choice | Pharvaris is a clinical-stage company focused on bringing oral bradykinin-B2-rec... | - |
|
Zug | Switzerland (HQ) + 2 | 2015 | Biotechnology, Health Care +2 | [email protected] |
1
Low
|
116
|
2.8K (-35%) | 1 year ago | Post Ipo Equity | 5 | 532.3M | 7077 | 5 months ago | ||
|
Ancora.ai | - | Ancora.ai is a patient-first, digital clinical trial navigation tool connecting... | Our vision at Ancora.ai is that all cancer patients have access to clinical rese... | - |
|
Zurich | Switzerland (HQ) + 2 | 2017 | AI, Big Data +3 | [email protected] |
1
Low
|
9
|
1.2K (9%) | 2 years ago | Grant | 6 | 481.7K | 1767 | 5 months ago | ||
|
Rocketvax AG | - | Implementing cutting-edge science in next-generation vaccine design that will im... | The company brings together both scientific and operational expertise from vario... | - |
|
Basel | Switzerland (HQ) | 2020 | Biotechnology, Health Care +2 | [email protected] |
1
Low
|
6
|
618 | 3 years ago | Grant | 3 | 5.2M | 871 | 5 months ago | ||
|
Stallergenes Greer | - | Enabling precision medicine to improve life for people with allergies | Stallergenes Greer is a global biopharmaceutical company specialising in the dia... | - |
|
Baar | Switzerland (HQ) | 2015 | Biopharma, Health Care +2 | - |
1
Low
|
1080
|
18.0K (-28%) | 8 years ago | Post Ipo Debt | 1 | 50.0M | 29373 | 5 months ago | ||
|
Quercis Pharma | - | For a Healthier World | Quercis Pharma AG is leveraging its novel antithrombotic platform to deliver saf... | - |
|
Zug | Switzerland (HQ) | 2019 | Biopharma, Biotechnology +2 | [email protected] |
1
Low
|
4
|
668 (374%) | 3 years ago | Private Equity | 1 | 150.0M | 78259 | 3 qtT H8L | ||
|
flowbone SA | - | A New Generation of Injectable Biomaterials for a Quick and Subtle, Local Streng... | At flowbone, we aim for a world where the elderly can enjoy a high level of inde... | - |
|
Lausanne | Switzerland (HQ) | 2020 | Health Care, Health and Wellness +4 | [email protected] |
1
Low
|
5
|
612 | 2 years ago | Seed | 6 | 3.2M | 1187 | 5 months ago | ||
|
Noema Pharma | - | Developing therapies to restore functioning in patients with orphan conditions o... | Noema Pharma is a biotech company developing groundbreaking therapies to address... | - |
|
Basel | Switzerland (HQ) | 2019 | Biotechnology, Pharmaceutical | [email protected] |
1
Low
|
32
|
3.1K | 2 years ago | Series B | 2 | 157.0M | 4301 | 5 months ago | ||
|
CHORD Therapeutics | - | Chord Therapeutics is dedicated to bringing new treatments to patients affected... | Chord Therapeutics is a clinical-stage pharmaceutical company developing drugs f... | - |
|
Geneva | Switzerland (HQ) | 2014 | Biotechnology, Pharmaceutical | [email protected] |
1
Low
|
725
|
739 | 4 years ago | Series A | 2 | 16.0M | 93273 | 10 yY0 t5E | ||
|
Testmate Health | - | Sex is fun. Testmate makes it safe. | Testmate Health is a an early stage healthcare startup focused on low cost, high... | - |
|
Lausanne | Switzerland (HQ) | 2020 | Biotechnology, Health Care +3 | [email protected] |
1
Low
|
13
|
243 | 1 year ago | Seed | 9 | 8.8M | 3081 | 6 months ago | ||
|
Scantrust | - | Anti-counterfeiting, product traceability, and consumer engagement for complianc... | Scantrust is a software platform for anti-counterfeiting and product traceabilit... | - |
|
Lausanne | Switzerland (HQ) | 2014 | Big Data, IoT +4 | [email protected] |
1
Low
|
45
|
139.1K (5%) | 2 years ago | Grant | 15 | 8.1M | 4521 | 6 months ago | ||
|
Oculis | - | Oculis develops eye drops to treat ophthalmic diseases, improving patients' live... | Oculis is a global biopharmaceutical company (Nasdaq: OCS; XICE: OCS) purposeful... | - |
|
Lausanne | Switzerland (HQ) + 2 | 2017 | Biotechnology, Health Care +1 | [email protected] |
1
Low
|
54
|
3.1K | 1 year ago | Post Ipo Equity | 13 | 384.6M | 4448 | 3 months ago | ||
|
PeakData | New open positions 2 Jobs | Making sense of HCP data spread across the web | PeakData helps pharmaceutical companies learn more about their customers through... | - |
|
Zug | Switzerland (HQ) | 2017 | AI, Pharmaceutical +1 | - |
2
Normal
|
53
|
1.1K (91%) | 2 years ago | Series A | 3 | 12.3M | 2223 | 4 months ago | ||
|
Cube RM | - | Accelerate your Tendering Business with AI | Cube RM is the leading global Tender Software, AI & Data company, empowering Lif... | - |
|
Zurich | Switzerland (HQ) + 1 | 2017 | AI, IT +4 | [email protected] |
1
Low
|
37
|
334 | 3 years ago | Series A | 2 | 9.0M | 4929 | 3 months ago | ||
|
ObsEva SA | - | ObsEva. Nature meets Nurture |
Innovating Women’s Reproductive Health and Pregnancy Therapeutics ObsEva is a c... |
- |
|
Plan-les-ouates | Switzerland (HQ) | 2012 | Biotechnology, Health and Wellness +2 | [email protected] |
1
Low
|
9
|
482 (16%) | 5 years ago | Post Ipo Debt | 5 | 228.4M | 3168 | 6 jKD L4A | ||
|
EraCal Therapeutics | - | Towards an efficacious and well-tolerated appetite-suppressant using our innovat... | The biotech-company EraCal Therapeutics Ltd. is a spin-off of the University of... | - |
|
Basel | Switzerland (HQ) | 2018 | Biotechnology, Health Care +1 | - |
1
Low
|
6
|
987 (45%) | 5 years ago | Seed | 5 | 1.1M | 1998 | 6 months ago | ||
|
FluoSphera | - | The only company with a suite of systemic and high-throughput in vitro drug disc... | FluoSphera S.A. is the only company providing a suite of high-throughput, system... | - |
|
Geneva | Switzerland (HQ) | 2021 | Biotechnology, Life Sciences +1 | [email protected] |
1
Low
|
4
|
639 | 2 years ago | Debt Financing | 4 | 1.2M | 746 | 6 months ago | ||
|
Vandria SA | - | We develop first-in-class mitophagy inducers that rejuvenate cells to treat age-... | Vandria is a biopharmaceutical company that develops best-in-class small molecul... | - |
|
Lausanne | Switzerland (HQ) | 2021 | Manufacturing, Pharmaceutical | [email protected] |
1
Low
|
14
|
333 (-1%) | 1 year ago | Grant | 2 | 21.5M | 1153 | 5 months ago | ||
|
Basilea Pharmaceutica | - | For the benefit of patients | Basilea is a commercial-stage biopharmaceutical company founded in 2000 and head... | - |
|
Allschwil | Switzerland (HQ) | 2000 | Biotechnology, Pharmaceutical | [email protected] |
1
Low
|
215
|
600 (-100%) | 1 year ago | Grant | 4 | 84.7M | 17754 | 5 months ago | ||
|
Versantis | - | Multiorgan support for rare pediatric and acute liver diseases | Versantis is a clinical-stage pharmaceutical company developing a new generation... | - |
|
Zurich | Switzerland (HQ) | 2015 | Health Care, Health and Wellness +1 | [email protected] |
1
Low
|
2
|
633 | 3 years ago | Grant | 8 | 21.1M | 2388 | 6 e8D 1m8 | ||
|
Santhera Pharmaceuticals | - | We are dedicated to developing medicines to meet the needs of patients living wi... | Santhera Pharmaceuticals (SIX: SANN) is a Swiss specialty pharmaceutical company... | - |
|
Pratteln | Switzerland (HQ) | 2004 | Biotechnology, Health Care +1 | [email protected] |
1
Low
|
93
|
4.4K (-34%) | 11 months ago | Post Ipo Debt | 12 | 270.7M | 17862 | 5 months ago | ||
|
RELIEF THERAPEUTICS Holdi... | - | Providing relief to patients with unmet medical needs in select specialty and ra... | RELIEF THERAPEUTICS Holding SA (SIX: RLF; OTCQB: RLFTF, RLFTY) We are a biopharm... | - |
|
Geneve | Switzerland (HQ) | 2013 | Biotechnology, Pharmaceutical | [email protected] |
1
Low
|
9
|
11.0K (-20%) | 1 year ago | Post Ipo Equity | 5 | 92.4M | 3786 | 1 year ago | ||
|
AC Immune | - | Shifting the treatment paradigm for neurodegenerative disease towards precision... | AC Immune SA is a clinical-stage biopharmaceutical company and a global leader i... | - |
|
Lausanne | Switzerland (HQ) | 2003 | Biotechnology, Health and Wellness +1 | [email protected] |
1
Low
|
179
|
13.6K (81%) | 1 year ago | Post Ipo Equity | 5 | 167.5M | 16522 | 5 months ago | ||
|
BC Platforms | - | From Data to Health | BC Platforms is a global leader in Real-World Data, Technology Platforms and Ser... | - |
|
Zurich | Switzerland (HQ) + 4 | 1997 | Analytics, Health Care +2 | [email protected] |
1
Low
|
153
|
2.7K (-40%) | 2 years ago | Private Equity | 4 | 45.3M | 8590 | 5 months ago | ||
|
SkyCell AG | - | Safe. Secure. Sustainable. | Welcome to SkyCell, the pioneering Swiss company revolutionizing global pharmace... | - |
|
Zurich | Switzerland (HQ) + 1 | 2013 | Logistics, Pharmaceutical +2 | [email protected] |
1
Low
|
203
|
20.1K (103%) | 11 months ago | Series D | 7 | 214.7M | 33569 | 5 months ago | ||
|
iOnctura | 5 days ago mentioned on Tech. (View) | Developing precision small molecules to combat hard-to-treat tumors. | iOnctura is a clinical-stage biopharmaceutical company combating neglected and h... | - |
|
Geneve | Switzerland (HQ) + 1 | 2017 | Biotechnology, Health Care +2 | [email protected] |
1
Low
|
28
|
3.0K (-27%) | 11 months ago | Series B | 9 | 127.7M | 4401 | 11 months ago | ||
|
ImmunOs Therapeutics AG | - | Novel human immunomodulatory proteins for cancer and autoimmune diseases with a... | ImmunOs Therapeutics AG is developing the next generation of immunotherapies tha... | - |
|
Schlieren | Switzerland (HQ) | 2014 | Biotechnology, Health Care +1 | [email protected] |
1
Low
|
15
|
2.1K (126%) | 3 years ago | Series B | 6 | 88.6M | 5700 | 8 months ago | ||
|
BioVersys AG | - | Leadership in overcoming the antibiotic resistance crisis. | BioVersys AG is a privately-owned clinical stage Swiss pharmaceutical company fo... | - |
|
Basel | Switzerland (HQ) | 2010 | Biotechnology, Pharmaceutical | [email protected] |
1
Low
|
27
|
2.0K (-33%) | 1 year ago | Series C | 14 | 113.3M | 6054 | 5 months ago | ||
|
domo.health | - | Empowering Health Together | We believe in the transformative power of a holistic, patient-centric digital he... | - |
|
Lausanne | Switzerland (HQ) + 1 | 2012 | Health Care, Pharmaceutical | [email protected] |
1
Low
|
23
|
211 (-79%) | 1 year ago | Non Equity Assistance | 10 | 16.9M | 3466 | 5 months ago | ||
|
Versameb AG | - | The next generation of RNA therapeutics | Versameb AG is a privately held biotechnology company focusing on discovering an... | - |
|
Basel | Switzerland (HQ) | 2017 | Biotechnology, Pharmaceutical | [email protected] |
1
Low
|
13
|
1.1K (317%) | 1 year ago | Seed | 5 | 26.7M | 2571 | 8 months ago | ||
|
Abionic | - | Lab-quality results within minutes, at the point-of-care! | The winner of multiple industry awards, including "Swiss MedTech of the year" in... | - |
|
Epalinges | Switzerland (HQ) | 2010 | Biotechnology, Health Care +2 | [email protected] |
1
Low
|
28
|
305 (-86%) | 1 year ago | Grant | 9 | 26.6M | 6187 | 5 months ago | ||
|
Limula | - | Cell & Gene Therapy: Automated. Scalable. Accessible | Limula provides an innovative solution for the production of the most personalis... | - |
|
Epalinges | Switzerland (HQ) + 1 | 2020 | Biotechnology, Manufacturing +1 | [email protected] |
1
Low
|
25
|
4.5K (105%) | 1 year ago | Seed | 12 | 15.2M | 5374 | 5 months ago | ||
|
Opterion Health AG | - | Renewing Renal Care | Opterion Health is focused to bring innovation to dialysis and foster peritoneal... | - |
|
Muttenz | Switzerland (HQ) | 2012 | Biotechnology, Health Care +1 | [email protected] |
1
Low
|
14
|
1.1K (103%) | 1 year ago | Debt Financing | 2 | 17.4M | 543 | 8 months ago | ||
|
Bionter | - | Revolutionizing analytical testing to benefit people's health |
Revolutionizing analytical testing for the benefit of people’s health. Our firs... |
- |
|
Basel | Switzerland (HQ) | 2020 | Health Care, Pharmaceutical | - |
1
Low
|
5
|
859 (-100%) | 3 years ago | Seed | 1 | 3.0M | 1360 | 10 months ago | ||
|
Remedok | - | REMEDOK est une plateforme B2B qui a pour but de diminuer le gaspillage des médi... | Traduite en trois langues (DE, FR, IT), Remedok permet aux pharmacies de mettre... | - |
|
Lausanne | Switzerland (HQ) | 2018 | Health Care, Pharmaceutical | [email protected] |
1
Low
|
2
|
404 | 4 years ago | Debt Financing | 1 | 50.0K | 61 | 2 quL 11R | ||
|
HpVac | - | A revolution in the first-line treatment of allergic diseases is under way | HpVac is focused on the development of a preventive and therapeutic first-line t... | - |
|
Geneva | Switzerland (HQ) | 2016 | Biotechnology, Health Care +1 | [email protected] |
1
Low
|
3
|
67 | 4 years ago | Seed | 3 | 2.4M | 486 | 1 year ago | ||
|
KYLYS | - | BIOMOLECULES NOW, FOR YOUR FUTURE | KYLYS is a Life Science Spin-off from the University of Geneva, now ready to ste... | - |
|
Plan-les-ouates | Switzerland (HQ) | 2017 | Biotechnology, Life Sciences +1 | - |
1
Low
|
3
|
932 | 2 years ago | Debt Financing | 2 | 100.0K | 438 | 1 year ago | ||
|
Light Chain Bioscience |... | - | Light Chain Bioscience – A brand of Novimmune SA | NovImmune has successfully divested EmaCo AG, a newly established company owning... | - |
|
Plan-les-ouates | Switzerland (HQ) | 1998 | Biotechnology, Pharmaceutical | - |
1
Low
|
85
|
567 (-100%) | - | Series C | - | 239.1M | 7687 | 6 months ago | ||
|
Addex Therapeutics | - | Allosteric modulators for Human Health | Addex Therapeutics is a clinical-stage pharmaceutical company focused on the dev... | - |
|
Plan-les-ouates | Switzerland (HQ) + 1 | 2002 | Biotechnology, Health Care +1 | [email protected] |
1
Low
|
19
|
276 (121%) | 1 year ago | Post Ipo Equity | 15 | 203.9M | 6629 | 6 months ago |